Crescent Sterling, Ltd. Bristol Myers Squibb CO Transaction History
Crescent Sterling, Ltd.
- $105 Billion
- Q3 2024
A detailed history of Crescent Sterling, Ltd. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Crescent Sterling, Ltd. holds 7,175 shares of BMY stock, worth $397,853. This represents 0.35% of its overall portfolio holdings.
Number of Shares
7,175
Previous 9,173
21.78%
Holding current value
$397,853
Previous $381 Million
2.55%
% of portfolio
0.35%
Previous 0.36%
Shares
8 transactions
Others Institutions Holding BMY
# of Institutions
2,453Shares Held
1.5BCall Options Held
29.6MPut Options Held
32.1M-
Vanguard Group Inc Valley Forge, PA187MShares$10.3 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.8 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$5.07 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$4.14 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$3.27 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $118B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...